Innate Immune Responses to Respiratory Syncytial Virus Infection
- 21 December 2013
- book chapter
- Published by Springer Nature
- Vol. 372, 139-154
Abstract
The innate immune response has a critical role in the initial stages of respiratory syncytial virus (RSV) infection and provides important instructional control that determines the direction of the acquired immune response and the severity of subsequent disease. Contributions to innate immunity include responses initiated in epithelial cells, dendritic cells, and macrophages. The initiation and the intensity of the response depends upon the recognition of pathogen-associated molecular patterns (PAMPs) that activate various pattern recognition receptors (PRRs) such as toll-like receptors (TLR), RIG-I–like receptors (RLR), and NOD-like receptors (NLR), that induce innate cytokines and chemokines that promote inflammation and direct the recruitment of immune cells as well as promote anti-viral responses. In this review, we summarize the results of numerous studies that have characterized the innate immune responses that contribute to the RSV-induced responses and may be important considerations for the development of efficacious vaccine strategies.Keywords
This publication has 57 references indexed in Scilit:
- Sendai virus-based RSV vaccine protects African green monkeys from RSV infectionVaccine, 2012
- Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these yearsVirus Research, 2011
- Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus–induced inflammation and infectionProceedings of the National Academy of Sciences, 2009
- Activation of innate immune antiviral responses by Nod2Nature Immunology, 2009
- Gene Expression of Nucleic Acid-Sensing Pattern Recognition Receptors in Children Hospitalized for Respiratory Syncytial Virus-Associated Acute BronchiolitisClinical and Vaccine Immunology, 2009
- TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severityVaccine, 2009
- Th1–Th2 polarisation and autophagy in the control of intracellular mycobacteria by macrophagesVeterinary Immunology and Immunopathology, 2009
- CXCL10/CXCR3‐mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8+ T cell efficacyEuropean Journal of Immunology, 2008
- Notch ligand Delta-like 4 regulates disease pathogenesis during respiratory viral infections by modulating Th2 cytokinesJournal of Experimental Medicine, 2007
- Autophagosome formation: core machinery and adaptationsNature Cell Biology, 2007